Literature DB >> 26153461

FRET evidence for untwisting of amyloid fibrils on the surface of model membranes.

Galyna Gorbenko1, Valeriya Trusova, Mykhailo Girych, Emi Adachi, Chiharu Mizuguchi, Kenichi Akaji, Hiroyuki Saito.   

Abstract

Apolipoprotein A-I (apoA-I) is an amyloid-forming protein whose amyloidogenic properties are attributed mainly to its N-terminal fragment. Cell membranes are thought to be the primary target for the toxic amyloid aggregates. In the present study Förster resonance energy transfer (FRET) between the membrane fluorescent probe Laurdan as a donor and amyloid-specific dye Thioflavin T (ThT) as an acceptor was employed to explore the interactions of amyloid fibrils from apoA-I variants 1-83/G26R and 1-83/G26R/W@8 with the model membranes composed of phosphatidylcholine and its mixture with cholesterol. The changes in FRET efficiency upon fibril-lipid binding were found to correlate with the extent of protein fibrillization. AFM imaging revealed the presence of two polymorphic states of fibrillar 1-83/G26R/W@8 with the helical and twisted ribbon morphologies. The simulation-based analysis of the experimental FRET profiles provided the arguments in favor of untwisting of fibrillar assemblies upon their interaction with the model membranes. Evidence for the face-on orientation and superficial bilayer location of the membrane-bound fragments of 1-83/G26R/W@8 fibrils was obtained.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26153461     DOI: 10.1039/c5sm00183h

Source DB:  PubMed          Journal:  Soft Matter        ISSN: 1744-683X            Impact factor:   3.679


  2 in total

1.  Shape Selection of Surface-Bound Helical Filaments: Biopolymers on Curved Membranes.

Authors:  David A Quint; Ajay Gopinathan; Gregory M Grason
Journal:  Biophys J       Date:  2016-10-04       Impact factor: 4.033

2.  The twisted tauopathies: surface interactions of helically patterned filaments seen in alzheimer's disease and elsewhere.

Authors:  Nash D Rochman; Sean X Sun
Journal:  Soft Matter       Date:  2015-11-03       Impact factor: 3.679

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.